Loading
A phase 1 trial of FID-007 run by University of Southern California, terminated.
FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer is a phase 1 interventional study registered as NCT06338657 by University of Southern California, with 1 participants enrolled, started 2024-04-01. Conditions recorded: Head and Neck Squamous Cell Carcinoma. Interventions recorded: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, PEOX-based Polymer Encapsulated Paclitaxel FID-007 and Tumor Resection.
Shares FID-007, Fulgent Genetics and the tag pipeline.
Shares FID-007, Fulgent Genetics, Head and neck squamous cell carcinoma and the tag pipeline.
Shares Fulgent Genetics and the tag pipeline.
Shares Fulgent Genetics and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/